Oruka Therapeutics ORKA

Agarwal Arjun (Officer) plans to sell 28,588 ORKA shares, about $2.5M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jul 13, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Exercise of Stock Options
  4. 10b5-1 plan adopted: Feb 11, 2026

All of Agarwal Arjun's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 3,743 shares at $84.26 on Jul 13, 2026 · Form 4
  • Sold 5,656 shares at $84.9 on Jul 13, 2026 · Form 4
  • Sold 2,100 shares at $104.67 on Aug 13, 2026 · Form 4
  • Sold 2,132 shares at $105.57 on Aug 13, 2026 · Form 4
  • Sold 1,268 shares at $106.63 on Aug 13, 2026 · Form 4
  • Sold 2,142 shares at $107.71 on Aug 13, 2026 · Form 4
  • Sold 2,358 shares at $108.46 on Aug 13, 2026 · Form 4
  • Sold 3,000 shares at $91.11 on Sep 11, 2026 · Form 4
  • Sold 4,051 shares at $92.41 on Sep 11, 2026 · Form 4
  • Sold 2,208 shares at $93.26 on Sep 11, 2026 · Form 4
  • Sold 200 shares at $94.02 on Sep 11, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Get an email when Oruka Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.